Treatment of pain in Ambulance Services with Sufenta® nasally compared toMorfin® intravenously.
- Conditions
- Severe pain treated in ambulance service.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- EUCTR2011-005366-38-SE
- Lead Sponsor
- Ambulance Service, Stockholm City Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria
Patients in the ambulance service of Stockholm City Council who fulfill the criteria for treatment of pain with opioids according to the local medical guidelines.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 350
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 350
Exclusion Criteria
Patientes younger than 18 years of age. Patients unable to participate in measurment of pain with VAS analogue scale. Patients with injuries to face or head making nasal administration not advisable.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method